PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a regulatory and QA consultancy from Korea

Selling into Europe as a regulatory and QA consultancy from Korea

Your consultants answer European regulatory questions on the spot, so bids stay alive.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Korea, Regulatory and QA consultancywho it is written for

Why this training matters

In a bid meeting, a European client asks which part of EudraLex Volume 4 applies to a deviation, and your lead consultant says they will check. The pause is short. The client hears it anyway, asks harder questions, and a local competitor gets the next call.

What changes after this course

Your team names Directive 2001/83/EC, Medical Device Regulation 2017/745 and EudraLex Volume 4 requirements in the meeting, and flags gaps in an entry plan before the contract is signed. You hold a certificate per learner and a training record per person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

A client describes a new active substance, and your consultant says on the spot whether it goes through the centralised procedure at the European Medicines Agency or to a National Competent Authority. They cite Directive 2001/83/EC and Regulation (EC) No 726/2004 while the client is still in the room. The application then goes in with a pharmacovigilance system summary that validation does not bounce.

Technical files for devices get a first review against Medical Device Regulation 2017/745 Annex II before a Notified Body sees them, so your team finds the missing clinical evidence, not the assessor. Adverse event cases go into EudraVigilance in the right format. A stalled In Vitro Diagnostic Regulation 2017/746 assessment gets a checklist instead of a shrug.

When a client is inspected, your staff has the document request process set up before the inspector arrives. They read sterile manufacturing records against Annex 1 of EudraLex Volume 4 and catch the contamination control gap before batch release. Audit responses name the root cause, so the corrective and preventive action holds.

Proposals leave your desk with a clear scope of work and liability clauses written for European practice. Client clinical data is handled under the General Data Protection Regulation from the first email. Gap analysis reports carry the formal, direct tone European pharmaceutical executives expect from a regulatory adviser.

Who needs this training

  • Regulatory Affairs Manager

    A client emails a simple question on Medical Device Regulation 2017/745 classification, and the answer takes a day of searching. After this course the reply goes out the same morning, with the classification rule cited.

  • Quality Assurance Lead

    They review a client's sterile line against Annex 1 of EudraLex Volume 4 and need to find the gap before the inspector does, not a week after the visit.

  • Business Development Director

    In a pitch to a European pharmaceutical company, the client asks what the Qualified Person for Pharmacovigilance is responsible for. The answer comes without a glance at a colleague.

  • Senior Consultant

    Drafting a service agreement, they must keep the firm from carrying the blame when a client's European Medicines Agency submission slips. The scope and liability clauses are settled before anyone signs.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Regulatory and QA consultancy

Countries: Korea

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Choose between the centralised, decentralised, mutual recognition and national procedures for a new medicinal product and justify the choice to a client.
  2. Draft a pharmacovigilance system summary and check a marketing authorisation dossier for gaps that would stop the review clock.
  3. Classify a product correctly under Medical Device Regulation 2017/745 and name the conformity assessment route that follows.
  4. Audit a sterile manufacturing site against Annex 1 of EudraLex Volume 4 and write findings an inspector would recognise.
  5. Format an individual case safety report for EudraVigilance and decide when a serious event must be escalated.
  6. Write a service agreement with a defined scope of work and liability clauses that address client market delays.
  7. Set up a back room that gets requested documents to European inspectors within minutes.

What the company gets

  • Your firm stops losing European bids to hesitant answers about local regulations.
  • Technical files reach Notified Bodies with the clinical evidence already checked, so fewer rounds of rework land on your desk.
  • Service agreements fix the scope of regulatory work, so a client's extra requests become a priced change instead of a free favour.
  • When an inspector asks for EudraLex Volume 4 documents, your team hands them over in an order they have practised.
  • Each learner finishes with a certificate, and you keep a training record per person to show a client or an auditor.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Tell clients which authority decides: European Medicines Agency or national

    • Why the European Medicines Agency recommends but the European Commission grants the authorisation.
    • The work split between the European Medicines Agency and national authorities, so you call the right desk.
    • When the centralised procedure is compulsory and when your client gets a choice.
  2. 2File a marketing authorisation application that keeps the review clock running

    • How to pick between the centralised, decentralised, mutual recognition and national routes.
    • What to put in the pharmacovigilance system summary so the application is not sent back.
    • The dossier gaps that stop the review clock, and how to find them before submission.
  3. 3Classify a product under MDR 2017/745 and IVDR 2017/746

    • How to classify a product under Medical Device Regulation 2017/745 so the pathway is right from day one.
    • What a Notified Body expects in the technical documentation, so the first review raises fewer questions.
    • What to do when an In Vitro Diagnostic Regulation 2017/746 conformity assessment stalls.
  4. 4Audit a site against European Good Manufacturing Practice Parts I and II

    • How to audit a finished product site against EudraLex Volume 4 Part I, chapter by chapter.
    • The active substance checks Part II expects, and how to show them on paper.
    • Why a sterile manufacturing deviation under Annex 1 is the one you chase before anything else.
  5. 5Build a quality system that passes ICH Q10 and ISO 13485 review

    • How to write a corrective and preventive action procedure that stops the same finding coming back.
    • The management review inputs ISO 13485 requires, listed so you can check a client's minutes.
    • What to check in an ICH Q10 system before an inspector asks to see the quality manual.
  6. 6Set up EudraVigilance reporting and a Post-Market Surveillance plan

    • How to format an individual case safety report so EudraVigilance accepts it on first submission.
    • The content a Post-Market Surveillance plan must hold under Medical Device Regulation Annex III.
    • When a serious adverse event must be escalated, and to whom, before the reporting deadline runs out.
  7. 7Pass a National Competent Authority audit with documents ready on request

    • How to set up a back room so inspectors get the documents they ask for in minutes, not hours.
    • The data integrity questions European inspectors raise, with the answers prepared beforehand.
    • What to write in an audit response so a major finding can be closed on paper.
  8. 8Draft service agreements that limit your risk with European clients

    • How to define the scope of work so a client stops asking for one more free revision.
    • The liability clauses that keep your firm out of a client's market delay claim.
    • Why keeping rights to your regulatory templates saves rewriting them for the next client.
  9. 9Plan your European market entry and the services you sell first

    • How to find mid-sized European device makers that need a partner for Korean market access.
    • The regulatory problems that push a European pharmaceutical executive to call in an outside consultant.
    • What to put in a first proposal so a local European firm is not the easier choice.
  10. 10Pitch and report to European pharmaceutical clients so they read on

    • How to structure a gap analysis report so a European executive reads past page one.
    • The communication differences that can cost a deal before the first formal meeting.
    • Why formal wording in early emails marks your firm as a serious regulatory adviser.
  11. 11Catch errors in Annex 1 and clinical evidence documents before clients do

    • How to spot the missing clinical data that holds up a conformity assessment.
    • The common gaps in sterile manufacturing records that put a batch release at risk.
    • What to do when a client has not updated the dossier after a manufacturing change.
  12. 12Handle client data under General Data Protection Regulation and local law

    • How to handle client clinical data without breaching the General Data Protection Regulation.
    • The habits that keep your consultants current when European directives change.
    • Why overlooking local tax rules in a client contract eats into your budget.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Korea, Regulatory and QA consultancy. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team